Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · IEX Real-Time Price · USD
1.700
+0.050 (3.03%)
At close: May 2, 2024, 4:00 PM
1.690
-0.010 (-0.59%)
After-hours: May 2, 2024, 7:59 PM EDT
Lexicon Pharmaceuticals Revenue
Lexicon Pharmaceuticals had revenue of $2.31M in the twelve months ending March 31, 2024, with 1,734.13% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.13M with 4,608.33% year-over-year growth. In the year 2023, Lexicon Pharmaceuticals had annual revenue of $1.20M with 766.19% growth.
Revenue (ttm)
$2.31M
Revenue Growth
+1,734.13%
P/S Ratio
181.13
Revenue / Employee
$8,109
Employees
285
Market Cap
418.60M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.20M | 1.07M | 766.19% |
Dec 31, 2022 | 139.00K | -159.00K | -53.36% |
Dec 31, 2021 | 298.00K | -23.70M | -98.76% |
Dec 31, 2020 | 24.00M | -298.08M | -92.55% |
Dec 31, 2019 | 322.07M | 258.86M | 409.54% |
Dec 31, 2018 | 63.21M | -28.48M | -31.06% |
Dec 31, 2017 | 91.69M | 12.43M | 15.69% |
Dec 31, 2016 | 79.26M | -50.76M | -39.04% |
Dec 31, 2015 | 130.01M | 107.16M | 468.89% |
Dec 31, 2014 | 22.85M | 20.63M | 928.53% |
Dec 31, 2013 | 2.22M | 1.13M | 104.04% |
Dec 31, 2012 | 1.09M | -760.00K | -41.10% |
Dec 31, 2011 | 1.85M | -3.06M | -62.33% |
Dec 31, 2010 | 4.91M | -5.79M | -54.13% |
Dec 31, 2009 | 10.70M | -21.62M | -66.89% |
Dec 31, 2008 | 32.32M | -17.80M | -35.51% |
Dec 31, 2007 | 50.12M | -22.68M | -31.15% |
Dec 31, 2006 | 72.80M | -2.88M | -3.81% |
Dec 31, 2005 | 75.68M | 13.94M | 22.58% |
Dec 31, 2004 | 61.74M | 18.90M | 44.12% |
Dec 31, 2003 | 42.84M | 7.64M | 21.70% |
Dec 31, 2002 | 35.20M | 4.62M | 15.12% |
Dec 31, 2001 | 30.58M | 16.12M | 111.47% |
Dec 31, 2000 | 14.46M | 9.72M | 205.17% |
Dec 31, 1999 | 4.74M | 2.50M | 111.34% |
Dec 31, 1998 | 2.24M | 1.27M | 131.66% |
Dec 31, 1997 | 967.74K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Revance Therapeutics | 234.04M |
GeneDx Holdings | 202.57M |
Anika Therapeutics | 166.66M |
ADC Therapeutics | 69.56M |
MaxCyte | 41.29M |
Mersana Therapeutics | 36.86M |
Cartesian Therapeutics | 26.00M |
LXRX News
- 9 hours ago - Lexicon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 3 days ago - Lonnel Coats Retires as Chief Executive Officer and Board Member of Lexicon Pharmaceuticals - GlobeNewsWire
- 14 days ago - Lexicon Pharmaceuticals to Host 2024 Investor Day - GlobeNewsWire
- 5 weeks ago - Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo - GlobeNewsWire
- 7 weeks ago - Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities - GlobeNewsWire
- 4 months ago - Lexicon Pharmaceuticals To Participate In The 42nd Annual JPMorgan Healthcare Conference - GlobeNewsWire
- 5 months ago - Lexicon Enrolls First Patient in Phase 2b Progress Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP) - GlobeNewsWire